SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-017250
Filing Date
2020-08-10
Accepted
2020-08-10 11:24:17
Documents
54
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q govx20200630_10q.htm 10-Q 527072
2 EXHIBIT 31.1 ex_196779.htm EX-31.1 12994
3 EXHIBIT 31.2 ex_196780.htm EX-31.2 12999
4 EXHIBIT 32.1 ex_196781.htm EX-32.1 3902
5 EXHIBIT 32.2 ex_196782.htm EX-32.2 3766
  Complete submission text file 0001437749-20-017250.txt   2746632

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT govx-20200630.xml EX-101.INS 374667
7 XBRL TAXONOMY EXTENSION SCHEMA govx-20200630.xsd EX-101.SCH 37540
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE govx-20200630_cal.xml EX-101.CAL 26196
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20200630_def.xml EX-101.DEF 254357
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20200630_lab.xml EX-101.LAB 199736
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20200630_pre.xml EX-101.PRE 271285
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

IRS No.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52091 | Film No.: 201087993
SIC: 2834 Pharmaceutical Preparations